Home
Search
BIO International Convention   |   June 3-6, 2024

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Stuart Cable
VICE CHAIRMAN, GLOBAL CHAIR OF M&A, GOODWIN
Fireside Chat with Noubar Afeyan, CEO, Flagship Pioneering
Robert Califf, MD, MACC
FDA COMMISSIONER, U.S. FOOD AND DRUG ADMINISTRATION
A Conversation with Robert M. Califf, MD
Riccardo Canevari
CEO, RADIOPHARM THERANOSTICS
Radiopharm Theranostics
Livingston, New Jersey, United States
Ping Cao, ACA
CHIEF BUSINESS OFFICER, HENLIUS BIOTECH
Henlius Biotech
Milpitas, California, United States
Dawn Cardeiro, M.S.
DIRECTOR OF PRECISION MEDICINE, POINT32HEALTH
Prescient Diagnostics: Implications for Product Development and Reimbursement
Shawn Carlson
HEAD OF MARKET ACCESS, ROCHE DIAGNOSTICS
Prescient Diagnostics: Implications for Product Development and Reimbursement
Chris Carpenter
EXECUTIVE PARTNER, PRIVATE EQUITY, SOFINNOVA INVESTMENTS
The Evolving Landscape of Immunotherapy in Solid Cancers
Menlo Park, California, United States
Juan Carter
OUTREACH MANAGER, GIFFORDS CENTER FOR VIOLENCE INTERVENTION
The Life Sciences Industry: Taking a Public Health Approach to Ending the Gun Violence Epidemic
Patrizia Cavazzoni, MD
DIRECTOR, CENTER FOR DRUG EVALUATION AND RESEARCH, FDA
FDA Town Hall
Meenakshy Chakravorty, JD
SENIOR COUNSEL, DIGITAL AND DEVICES IP, SANOFI
IP for AI: Expanding a Biopharma IP Portfolio to Protect AI and Data Innovations
Boston, Massachusetts, United States